ENDPOINTS

Tenaya raises about $53M; BeiGene’s PD-1 gets a first-line approval

Plus, news about Evotec and Osivax: Tenaya Therapeutics’ $52.5M public offering: The heart disease specialist intends to spend the proceeds from its offering of 75 million new shares to develop treatments ...

Mar 4, 2025 - 16:07
 0
Tenaya raises about $53M; BeiGene’s PD-1 gets a first-line approval
Plus, news about Evotec and Osivax: Tenaya Therapeutics’ $52.5M public offering: The heart disease specialist intends to spend the proceeds from its offering of 75 million new shares to develop treatments ...
Read More

Tags:

Previous Article

All On Board! Review-In-Progress: More Than Just Fun And Games

Next Article

The AI Future Is Here

Related Posts

Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more

Q4 earnings updates; Biogen details revised research st...

Feb 9, 2025  0

FDA lifts hold on Entrada's Duchenne drug after two years

FDA lifts hold on Entrada's Duchenne drug after two years

Feb 24, 2025  0

How Bain’s $3.3B deal for a centuries-old Japanese pharma came to fruition

How Bain’s $3.3B deal for a centuries-old Japanese phar...

Feb 14, 2025  0